Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001553350-19-000394
Filing Date
2019-04-16
Accepted
2019-04-16 16:11:32
Documents
51
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ephs_10k.htm 10-K 433075
2 CERTIFICATION ephs_ex31z1.htm EX-31 8106
3 CERTIFICATION ephs_ex31z2.htm EX-31.2 8035
4 CERTIFICATION ephs_ex32z1.htm EX-32 3137
5 CERTIFICATION ephs_ex32z2.htm EX-32.2 3017
  Complete submission text file 0001553350-19-000394.txt   1980260

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE stnn-20181231.xml EX-101.INS 244109
7 XBRL SCHEMA FILE stnn-20181231.xsd EX-101.SCH 21057
8 XBRL CALCULATION FILE stnn-20181231_cal.xml EX-101.CAL 31355
9 XBRL DEFINITION FILE stnn-20181231_def.xml EX-101.DEF 88488
10 XBRL LABEL FILE stnn-20181231_lab.xml EX-101.LAB 171324
11 XBRL PRESENTATION FILE stnn-20181231_pre.xml EX-101.PRE 151634
Mailing Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4
Business Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4 212-321-0091
EPHS HOLDINGS, INC. (Filer) CIK: 0001731911 (see all company filings)

EIN.: 824383947 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55906 | Film No.: 19751093
SIC: 2834 Pharmaceutical Preparations